Molecular Diagnostics: The Technologies and Partnerships Redefining Clinical Care
Frost & Sullivan Podcasts
This episode of Frost & Sullivan’s Growth Podcast explores the strategic shifts shaping the molecular diagnostics industry, from AI-enabled data analysis and next-generation sequencing to decentralized testing and multi-omics liquid biopsy.
We examine how technology convergence, changing business models, and industry partnerships are influencing the development and clinical adoption of advanced molecular tests.
👉 How are new technologies changing molecular testing?
👉 What is driving the shift toward decentralized and value-based diagnostics?
👉 Where are the next growth opportunities emerging?
Designed for healthcare, diagnostics, strategy, and innovation leaders, this episode delivers focused insights into the technologies, investment priorities, and partnerships influencing the future of molecular diagnostics.
Explore related research:
https://www.frost.com | https://store.frost.com
Connect with our team: hello@frost.com
Loading